CBD Life Sciences Announces Its Proprietary "CBD+CBG Hand Sanitizer Gel Infused with Vitamin E Oil" Is Here! Place Your Order Today
- Wall Street extends slide on rising inflation fears
- Fed Has Already Changed its Policy Due to Inflation, Market Gambling Fears - Dick Bove
- U.S. consumer prices post largest gain since 2009 as inflation ramps up
- Bill Ackman said has been working on a transaction for Pershing Square Tontine (PSTH) for months
- FuboTV (FUBO) Surges After Crushing Views on New Subscribers Adds, Analysts Positive
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
SCOTTSDALE, AZ / ACCESSWIRE / April 15, 2020 / CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience "LBC Bio" is pleased to announce that our brand-new proprietary product 100 mg CBD + CBG with Vitamin E Hand Sanitizer has arrived to our facility. Our new Hand Sanitizer Gel product is in a 4 oz bottle containing CBD (cannabidiol) and CBG (cannabigerol) ingredients which will be marketed as "CBG+CBD Hand Sanitizer Gel Infused with Vitamin E Oil " is now available for purchase. You can place your order today on our website www.lbcbioscienceinc.com. Follow our social media accounts at www.instagram.com/lbcbioscience, www.twitter.com/lbcbioscience for updating information regarding LBC Bioscience Inc. CBD products.
Lisa Nelson, CEO of CBD Life Sciences, Inc. commented "During this Pandemic, hand sanitizer is one of the most out of stock products in all retail stores. LBC Bio Science Inc. is proud to provide the public with this most needed product. We do expect to sell our hand sanitizers quickly. In today's COVID-19 environment, keeping our hands clean and virus free is critical."
Lisa Nelson continued "We are now selling our new product on our website www.lbcbioscienceinc.com and also in our LBC Bioscience Inc. store located at 10855 North 116th Street. Suite 115 in Scottsdale, AZ 85259. We would look forward to meeting interested readers at our LBC Store and welcome their inquiries."
The Company also plans to offer its proprietary hand sanitizer in our upcoming Scottsdale Fashion Square mall kiosk. This is a quick update on our previously announced kiosk opening schedule of April 1, 2020. Due to the COVID-19's effects on retail malls, we will be postponing our Grand Opening until Fashion Square retail operations return to normal. Look for more information to come on the opening of our kiosk as retailer operations at Scottsdale Fashion Mall start to re-open for business. We cannot currently predict the exact timing of normal retailer operations but are confident that Scottsdale Fashion Mall will return to normalcy when today's extraordinary health crises do pass.
Lisa Nelson finished "We think that our new "CBG+CBD Hand Sanitizer Gel Infused with Vitamin E Oil" is timely and on point
given the public's current need to avoid today's COVID-19 viruses. We believe that the new norm will include using hand sanitizers on a regular basis and feel with the addition of this new product we are well positioned for the future."
About CBD Life Sciences Inc.
CBD Life Sciences Inc. is a publicly traded company having its common shares quoted on the OTC Markets under the symbol CBDL'. The Company's main focus is to identify, evaluate and acquire undervalued opportunities with the objective of increasing shareholder value. The acquisition of LBC Bioscience Inc. is the first in the CBD space and the Company is actively pursuing for additional opportunities within this emerging sector.
About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including: CBD hemp drops, pain relief creams, anxiety & sleep supplements, CBD edibles including brain booster coffee, weight loss coffee , anti-aging skin line and a full line of CBD infused supplements for your pets. LBC's products can be viewed and purchased on the Company's website at www.lbcbioscienceinc.com.
Contact Information Investor Relations
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE: CBD Life Sciences Inc.
View source version on accesswire.com:
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Xenetic Biosciences, Inc. Reports First Quarter 2021 Financial Results
- MCRA CRO Assists Simplify Medical, Recently Acquired by NuVasive, on FDA-Approval for Two Level use of its Cervical Disc
- Griffin Caprio Joins Popular Pays as Chief Product Officer
Create E-mail Alert Related CategoriesAccesswire, Press Releases
Related EntitiesTwitter, Definitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!